Cannabinoid receptor-mediated translocation of NO-sensitive guanylyl cyclase and production of cyclic GMP in neuronal cells

Neuropharmacology

Volumn 54, Issue 1, 2008, Pages 23-30

  Jones, Jenelle D ^a,b   Carney, Skyla T ^a   Vrana, Kent E ^b,c   Norford, Derek C ^a   Howlett, Allyn C ^a,b  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

CB1 cannabinoid receptor; CP55940; cyclic GMP; G protein coupled receptors; G proteins; Gene expression; NO sensitive guanylyl cyclase; Protein translocation; Real time polymerase chain reaction; Rimonabant (SR141716); WIN55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; CYCLIC GMP; GUANYLATE CYCLASE; NITRIC OXIDE; PERTUSSIS TOXIN; PROTEIN SUBUNIT; RECEPTOR SUBUNIT; RIMONABANT;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CANNABINOIDS; CELL LINE, TUMOR; CYCLIC GMP; DRUG INTERACTIONS; ENZYME INHIBITORS; GENE EXPRESSION; GUANYLATE CYCLASE; MICE; NEUROBLASTOMA; NITRIC OXIDE; PERTUSSIS TOXIN; PIPERIDINES; PROTEIN TRANSPORT; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; TIME FACTORS;

EID: 37349108156     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.06.027     Document Type: Article

References (51)

1. Balashova N., Chang F.J., Lamothe M., Sun Q., and Beuve A. Characterization of a novel type of endogenous activator of soluble guanylyl cyclase. J. Biol. Chem. 280 (2005) 2186-2196
2. Beardsley P.M., and Thomas B.F. Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders. Behav. Pharmacol. 16 (2005) 275-296
3. + current. J. Biol. Chem. 278 (2003) 46188-46194
4. Bisogno T., Ligresti A., and Di Marzo V. The endocannabinoid signalling system: biochemical aspects. Pharmacol. Biochem. Behav. 81 (2005) 224-238
5. Blum-Degen D., Heinemann T., Lan J., Pedersen V., Leblhuber F., Paulus W., Riederer P., and Gerlach M. Characterization and regional distribution of nitric oxide synthase in the human brain during normal ageing. Brain Res. 834 (1999) 128-135
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
7. Burette A., Zabel U., Weinberg R.J., Schmidt H.H., and Valtschanoff J.G. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J. Neurosci. 22 (2002) 8961-8970
8. Childers S.R., and Deadwyler S.A. Role of cyclic AMP in the actions of cannabinoid receptors. Biochem. Pharmacol. 52 (1996) 819-827
9. Di Marzo V., De Petrocellis L., Sepe N., and Buono A. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem. J. 316 (1996) 977-984
10. Di Marzo V., De Petrocellis L., Sugiura T., and Waku K. Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Biochem. Biophys. Res. Commun. 227 (1996) 281-288
11. Diana M.A., and Marty A. Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br. J. Pharmacol. 142 (2004) 9-19
12. Fowler C.J., Holt S., Nilsson O., Jonsson K.O., Tiger G., and Jacobsson S.O. The endocannabinoid signaling system: pharmacological and therapeutic aspects. Pharmacol. Biochem. Behav. 81 (2005) 248-262
13. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., and Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol. Pharmacol. 48 (1995) 184-188
14. Gibb B.J., and Garthwaite J. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur. J. Neurosci. 13 (2001) 539-544
15. Giordano D., De Stefano M.E., Citro G., Modica A., and Giorgi M. Expression of cGMP-binding cGMP-specific phosphodiesterase (PDE5) in mouse tissues and cell lines using an antibody against the enzyme amino-terminal domain. Biochim. Biophys. Acta 1539 (2001) 16-27
16. Hanafy K.A., Martin E., and Murad F. CCTeta, a novel soluble guanylyl cyclase-interacting protein. J. Biol. Chem. 279 (2004) 46946-46953
17. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., De Costa B.R., and Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11 (1991) 563-583
18. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., and Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 54 (2002) 161-202
19. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., and Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 Suppl. 1 (2004) S345-S358
20. Howlett, A.C., Carter, P., Jones, J.D., Vrana, K.E., 2002b. Changes in gene expression in response to cannabinoid and aminoalkylindole agonists. International Cannabinoid Research Society 12th Annual Symposium on the Cannabinoids, July 10-July 14, Pacific Grove, CA, USA.
21. Howlett A.C., and Fleming R.M. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol. Pharmacol. 26 (1984) 532-538
22. Howlett A.C., Qualy J.M., and Khachatrian L.L. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29 (1986) 307-313
23. Ibarra C., Nedvetsky P.I., Gerlach M., Riederer P., and Schmidt H.H. Regional and age-dependent expression of the nitric oxide receptor, soluble guanylyl cyclase, in the human brain. Brain Res. 907 (2001) 54-60
24. Jurado S., Sanchez-Prieto J., and Torres M. Elements of the nitric oxide/cGMP pathway expressed in cerebellar granule cells: biochemical and functional characterisation. Neurochem. Int. 45 (2004) 833-843
25. Kostic T.S., Andric S.A., and Stojilkovic S.S. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5′-monophosphate production in pituitary cells. Mol. Endocrinol. 18 (2004) 458-470
26. Kostic T.S., Tomic M., Andric S.A., and Stojilkovic S.S. Calcium-independent and cAMP-dependent modulation of soluble guanylyl cyclase activity by G protein-coupled receptors in pituitary cells. J. Biol. Chem. 277 (2002) 16412-16418
27. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
28. Louis J.C., Revel M.O., and Zwiller J. Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim. Biophys. Acta 1177 (1993) 299-306
29. Mackie K., Devane W.A., and Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44 (1993) 498-503
30. Mailleux P., and Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48 (1992) 655-668
31. Maslov L.N., Lasukova O.V., Krylatov A.V., Uzhachenko R.V., and Pertwee R. Selective cannabinoid receptor agonist HU-210 decreases pump function of isolated perfused heart: role of cAMP and cGMP. Bull. Exp. Biol. Med. 138 (2004) 550-553
32. 2 cannabinoid receptor-independent nitric oxide production in rabbit aortic endothelial cells. J. Pharmacol. Exp. Ther. 321 (2007) 930-937
33. Meschler J.P., Kraichely D.M., Wilken G.H., and Howlett A.C. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxylic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. Biochem. Pharmacol. 60 (2000) 1315-1323
34. Meurer S., Pioch S., Wagner K., Muller-Esterl W., and Gross S. AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. J. Biol. Chem. 279 (2004) 49346-49354
35. Mukhopadhyay S., Shim J.Y., Assi A.A., Norford D., and Howlett A.C. CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling. Chem. Phys. Lipids 121 (2002) 91-109
36. Papapetropoulos A., Zhou Z., Gerassimou C., Yetik G., Venema R.C., Roussos C., Sessa W.C., and Catravas J.D. Interaction between the 90 kDa heat shock protein and soluble guanylyl cyclase: physiological significance and mapping of the domains mediating binding. Mol. Pharmacol. 68 (2005) 1133-1141
37. Pazos M.R., Nunez E., Benito C., Tolon R.M., and Romero J. Functional neuroanatomy of the endocannabinoid system. Pharmacol. Biochem. Behav. 81 (2005) 239-247
38. Pyriochou A., and Papapetropoulos A. Soluble guanylyl cyclase: more secrets revealed. Cell Signal 17 (2005) 407-413
39. Rinaldi-Carmona M., Barth F., Heaulme M., Alonso R., Shire D., Congy C., Soubrie P., Breliere J.C., and Le Fur G. Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci. 56 (1995) 1941-1947
40. Russwurm M., Wittau N., and Koesling D. Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J. Biol. Chem. 276 (2001) 44647-44652
41. Schlicker E., and Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 22 (2001) 565-572
42. Schwarz P.M., Rodriguez-Pascual F., Koesling D., Torres M., and Forstermann U. Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Neuroscience 82 (1998) 255-265
43. Smolenski A., Bachmann C., Reinhard K., Honig-Liedl P., Jarchau T., Hoschuetzky H., and Walter U. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody. J. Biol. Chem. 273 (1998) 20029-20035
44. Sterin-Borda L., Del Zar C.F., and Borda E. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways. Biochem. Pharmacol. 69 (2005) 1705-1713
45. Sugiura T., Kodaka T., Kondo S., Tonegawa T., Nakane S., Kishimoto S., Yamashita A., and Waku K. Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells. Biochem. Biophys. Res. Commun. 233 (1997) 207-210
46. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., and Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83 (1998) 393-411
47. Vannacci A., Giannini L., Passani M.B., Di Felice A., Pierpaoli S., Zagli G., Fantappie O., Mazzanti R., Masini E., and Mannaioni P.F. The endocannabinoid 2-arachidonylglycerol decreases the immunological activation of guinea pig mast cells: involvement of nitric oxide and eicosanoids. J. Pharmacol. Exp. Ther. 311 (2004) 256-264
48. Venema R.C., Venema V.J., Ju H., Harris M.B., Snead C., Jilling T., Dimitropoulou C., Maragoudakis M.E., and Catravas J.D. Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H669-H678
49. Walz M.A., Holt I.L., and Howlett A.C. Cyclic nucleotide phosphodiesterase isozymes in neuroblastoma cells. J. Neurosci. Res. 17 (1987) 291-297
50. Westlake T.M., Howlett A.C., Bonner T.I., Matsuda L.A., and Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63 (1994) 637-652
51. Zabel U., Kleinschnitz C., Oh P., Nedvetsky P., Smolenski A., Muller H., Kronich P., Kugler P., Walter U., Schnitzer J.E., and Schmidt H.H. Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat. Cell Biol. 4 (2002) 307-311